Personalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
GC Therapeuticsgc-tx.com |
GC Therapeutics (GCTx) is a biotechnology company that uses synthetic biology to program patient-derived stem cells into any cell | Cambridge, Massachusetts | 11-50 | — |
Cellularistcellularist.com |
— | — | — | |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
CRISPR Therapeuticscrisprtx.com BLPP  DK |
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever appr | Boston, Massachusetts | 201-1000 | — |
Precisionbiosciencesprecisionbiosciences.com  CGMBNL |
Precision BioSciences (Nasdaq: DTIL) is a clinical-stage gene editing company based in Durham, North Carolina, developing in vivo | Durham, North Carolina | 51-200 | — |
Editas Medicineeditasmedicine.com LB  AKBM |
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipel | Cambridge, Massachusetts | 51-200 | — |
Intelliaintellia.com |
— | — | — | |
Vervetherapeuticsvervetherapeutics.com |
— | — | — | |
Scribescribe.bio |
— | — | — | |
Egenesisegenesis.com |
— | — | — | |
STRM.BIOstrm.bio  LG IT MS |
STRM.BIO is a pre-clinical biotechnology company developing a non-viral, cell-derived delivery platform using megakaryocyte-derive | Boston, Massachusetts | 11-50 | — |
Inscriptainscripta.com |
Inscripta (now Manus) is a bioalternatives company that scales biology to replace ingredients, materials, and products of the foss | Pleasanton, Colorado | 1-10 | — |
Crisprcrispr.com |
— | — | — | |
Logicbiologicbio.com |
— | — | — | |
Beam Therapeuticsbeamtx.com  LJGS AH |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
REGENXBIOregenxbio.com |
REGENXBIO is a clinical-stage biotechnology company founded in 2008 and headquartered in Rockville, Maryland, pioneering AAV gene | Rockville, Maryland | 201-1000 | — |
Graphite Biographitebio.com |
Graphite Bio is a clinical-stage, next-generation gene editing company based in South San Francisco, California, pioneering the Ul | South San Francisco, California | 1-10 | — |
Allogene Therapeuticsallogene.com |
Allogene Therapeutics is a clinical-stage biotechnology company developing investigational allogeneic chimeric antigen receptor T | South San Francisco, California | 201-1000 | — |
Homologymedicinehomologymedicine.com |
— | — | — | |
Cariboubiosciencescariboubiosciences.com |
— | — | — | |
Crisptherapeuticscrisptherapeutics.com |
— | — | — | |
| Run live for more | ||||
GC Therapeutics (GCTx) is a biotechnology company that uses synthetic biology to program patient-derived stem cells into any cell type with up to 10X efficiency, 100X speed, and scalability, with technology conceived in Professor George Church's lab at Harvard Medical School.
Companies like GC Therapeutics include Cellularist, Pregenen, CRISPR Therapeutics, Precisionbiosciences, Editas Medicine. See the full list of 24 competitors and alternatives above.
GC Therapeutics has approximately 11-50 employees and is in the Biotechnology Research industry.
GC Therapeutics is headquartered in Cambridge, Massachusetts.
GC Therapeutics operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at GC Therapeutics are listed above, including leaders across executive, finance, sales and operations.